Zelira Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Jun '25 Jun 20, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2019
Market Capitalization	5	3	17	9	51	52	Upgrade
Market Cap Growth	-31.11%	-81.46%	84.44%	-81.85%	-1.91%	72.70%	Upgrade
Enterprise Value	12	5	18	3	43	51	Upgrade
Last Close Price	0.42	0.28	1.51	0.97	7.53	9.45	Upgrade
PS Ratio	122.22	33.46	56.90	6.03	77.16	-	Upgrade
PB Ratio	-0.63	-0.76	0.54	0.26	1.35	1.51	Upgrade
P/TBV Ratio	-	-	70.09	2.66	8.59	20.70	Upgrade
EV/Sales Ratio	285.79	54.68	58.87	1.88	64.93	-	Upgrade
Debt / Equity Ratio	-0.79	-1.43	0.01	0.01	0.02	0.02	Upgrade
Asset Turnover	0.02	0.01	0.01	0.04	0.02	-	Upgrade
Inventory Turnover	0.15	0.24	0.36	0.67	-	-	Upgrade
Quick Ratio	0.02	0.41	0.08	1.85	4.68	2.63	Upgrade
Current Ratio	0.15	0.60	0.94	3.12	5.66	2.73	Upgrade
Return on Equity (ROE)	-	-266.82%	-18.60%	-33.77%	-23.62%	-37.26%	Upgrade
Return on Assets (ROA)	-92.12%	-18.87%	-12.51%	-21.42%	-15.60%	-24.62%	Upgrade
Return on Capital (ROIC)	-	-21.73%	-13.10%	-22.14%	-15.94%	-25.27%	Upgrade
Earnings Yield	-96.96%	-1150.98%	-32.53%	-128.58%	-16.70%	-13.44%	Upgrade
FCF Yield	-	-138.13%	-42.31%	-101.48%	-16.84%	-13.32%	Upgrade
Buyback Yield / Dilution	-3.60%	-12.70%	-25.19%	-21.25%	-36.81%	-12.37%	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.